Risks of Variant Creutzfeldt-Jakob Disease from Blood Transfusions
Author Information
Author(s): Liras Antonio
Primary Institution: Department of Physiology, Biology School, Universidad Complutense of Madrid, Spain
Hypothesis
What are the risks associated with the transmission of variant Creutzfeldt-Jakob disease (vCJD) through blood and blood derivatives?
Conclusion
The study highlights significant risks of transmitting vCJD through blood transfusions and emphasizes the need for improved safety measures.
Supporting Evidence
- Prions can be present in blood and are transmitted through this route.
- Emerging diseases pose new risks to blood safety.
- Historical data shows that blood transfusions have previously transmitted infectious diseases.
Takeaway
This study talks about how blood from donors who might have a disease called vCJD can make people sick, so we need to be very careful with blood donations.
Methodology
The study reviews historical data and current practices regarding blood transfusions and the risks of vCJD.
Potential Biases
Potential bias may arise from the reliance on theoretical models and historical data.
Limitations
The study lacks specific statistical data quantifying the risk of infection through plasma products.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website